| Date |
Title |
|
|
August 4, 2023
|
Fulgent Reports Second Quarter 2023 Financial Results
|
|
|
July 18, 2023
|
Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023
|
|
|
June 5, 2023
|
Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers
|
|
|
May 18, 2023
|
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual Meeting
|
|
|
May 5, 2023
|
Fulgent Reports First Quarter 2023 Financial Results
|
|
|
April 20, 2023
|
Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023
|
|
|
February 28, 2023
|
Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results
|
|
|
February 28, 2023
|
Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
|
|
|
February 23, 2023
|
Fulgent to Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
|
|
|
February 14, 2023
|
Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
|
|
|
January 3, 2023
|
Fulgent Expands Board of Directors with Addition of Reggie Groves
|
|
